Your browser doesn't support javascript.
loading
Surveillance Imaging Strategies for Pituitary Adenomas: When, How Frequent, and When to Stop.
Yuen, Kevin C J; Ghalib, Luma; Buchfelder, Michael; Hughes, Jeremy; Langlois, Fabienne; Molitch, Mark E.
Afiliação
  • Yuen KCJ; Department of Neuroendocrinology and Neurosurgery, Barrow Pituitary Center, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona; Department of Medicine, University of Arizona College of Medicine and Creighton School of Medicine, Phoenix, Arizona. Electronic addr
  • Ghalib L; The James Comprehensive Skull Base and Pituitary Center, Division of Endocrinology, The Ohio State University, Ohio.
  • Buchfelder M; Department of Neurosurgery, University of Erlangen-Nürnberg, Erlangen, Germany.
  • Hughes J; Department of Neuroradiology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona.
  • Langlois F; Division of Endocrinology, Department of Medicine, Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada.
  • Molitch ME; Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Endocr Pract ; 30(3): 282-291, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38160940
ABSTRACT

OBJECTIVE:

To describe a practical approach of when and how often to perform imaging, and when to stop imaging pituitary adenomas (PAs).

METHODS:

A literature review was carried out and recommendations provided are derived largely from personal experience.

RESULTS:

Magnetic resonance imaging is the mainstay imaging modality of choice in the assessment, treatment planning, and follow-up of PAs. These adenomas are discovered incidentally during imaging for a variety of unrelated conditions, because of clinical symptoms related to mass effects on the adjacent structures, or during workup for functional alterations of the adenoma. Imaging is also used in the preoperative and postoperative phases of assessment of PAs, for surgical and radiotherapy planning, for postoperative surveillance to assess for adenoma stability and detection of adenoma recurrence, and for surveillance to monitor for adenoma growth in unoperated PAs. Currently, because there are no evidence-based consensus recommendations, the optimal strategy for surveillance imaging of PAs is not clearly established. Younger age, initial adenoma size, extrasellar extension, mass effect, cavernous sinus invasion, functional status, histopathologic characteristics, cost considerations, imaging accessibility, patient preference, and patient contraindications (eg, implanted metallic devices and patient claustrophobia) are all important factors that influence the strategy for surveillance imaging.

CONCLUSIONS:

This review provides a practical approach of performing surveillance imaging strategies for PAs that should be individualized based on clinical presentation, history, adenoma morphology on imaging, and histopathologic characteristics.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hipofisárias / Adenoma Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hipofisárias / Adenoma Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article